Lorazepam Injection Shortage

Last Updated: September 16, 2025
Status: Current

Unavailable, Current:

• Ativan, Injection, 2 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
• Ativan, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
• Lorazepam, Injection, 2 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
• Lorazepam, Injection, 2 mg/1 mL Syringes (Hospira, Inc., a Pfizer Company)
• Lorazepam, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

Limited Availability, Current:

• Lorazepam, Injection, 2 mg/1 mL (Amphastar Pharmaceuticals, Inc.)

Ativan, Injection, 2 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6001-25
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Ativan, Injection, 2 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6000-10
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Ativan, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6003-25
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Ativan, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6002-10
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Lorazepam, Injection, 2 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6044-25
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Lorazepam, Injection, 2 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6046-10
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Lorazepam, Injection, 2 mg/1 mL Syringes (Hospira, Inc., a Pfizer Company)

NDC Code: 0409-1985-30
Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Next Delivery: August 2025; Estimated Recovery: December 2025
Therapeutic category: Neurology
Initial posting date: May 3, 2018
Contact info: 844-646-4398

Lorazepam, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6045-25
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: September 5, 2018
Contact info: 800-631-2174

Lorazepam, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)

NDC Code: 0641-6047-10
Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Revised
Reason for shortage: Regulatory delay
Related Information: Shortage duration unknown
Therapeutic category: Neurology
Initial posting date: May 3, 2018
Contact info: 800-631-2174

Lorazepam, Injection, 2 mg/1 mL (Amphastar Pharmaceuticals, Inc.)

NDC Code: 76329-8261-1
Availability: Limited Availability
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Therapeutic category: Neurology
Initial posting date: May 3, 2018
Contact info: 800-423-4136

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer